Lv1
90 积分 2025-04-06 加入
Immunotherapy in Lung Cancer: Current Landscape and Future Directions
3个月前
已完结
Impact of radiation dose to the immune cells in unresectable or stage III non-small cell lung cancer in the durvalumab era
3个月前
已完结
Safety and efficacy of radiotherapy combined with immunotherapy in limited-stage small cell lung cancer a single-arm meta-analysis and systematic review
3个月前
已关闭
Efficacy and Safety of Neoadjuvant Immunotherapy plus Chemotherapy versus Neoadjuvant Chemotherapy in Non‐Small Cell Lung Cancer Treatment: A Mixed Method Meta‐Analysis Based on Global Randomized Controlled Trials
4个月前
已完结
LBA84 Consolidation ipilimumab and nivolumab vs observation in limited stage SCLC after chemo-radiotherapy: Results from the ETOP/IFCT 4-12 STIMULI trial
4个月前
已完结
LBA84 Consolidation ipilimumab and nivolumab vs observation in limited stage SCLC after chemo-radiotherapy: Results from the ETOP/IFCT 4-12 STIMULI trial
4个月前
已完结
Maintenance or consolidation therapy in small-cell lung cancer: an updated systematic review and meta-analysis
4个月前
已完结
Concurrent immunotherapy improves progression-free survival but increases toxicity in unresectable stage III NSCLC
4个月前
已完结
Real-World Safety and Efficacy of Consolidation Durvalumab After Chemoradiation Therapy for Stage III Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis
4个月前
已完结
Predicting radiation pneumonitis in lung cancer patients using robust 4DCT-ventilation and perfusion imaging
4个月前
已完结
皖公网安备34019202002308
